 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2023 GLOBE NEWSWIRE ORIC Pharmaceuticals, Inc. Nasdaq: ORIC, a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare ... The post ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference appeared first on Fore... 